+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Small Molecule Drug Discovery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Therapeutic Area; Process/Phase; and Geography

  • ID: 5067611
  • Report
  • May 2020
  • Region: Global
  • 174 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2021
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Allergan Plc.
  • AstraZeneca
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc.
  • MERCK KGaA
  • Pfizer Inc.
  • MORE
The small molecule drug discovery market was valued at US$ 24,976.14 million in 2019 and is projected to reach US$ 50,823.06 million by 2027; it is expected to grow at a CAGR of 9.5% from 2020 to 2027.

There is increase in demand for small molecules in treatment of various chronic as well as rare diseases for which not much treatment options are available. Moreover, the increasing investments and R&D expenditures by the pharmaceutical players towards development of new targets and lead candidates for small molecules are also expected to foster the market growth. However, high cost involved in the drug discovery process expected to restrain the growth of the market during the forecast period.

Small molecules drugs are used in targeted drug delivery in which small molecules pass through the cell membrane and acts on the specific cellular organelle or protein. The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their small size, easy convertibility to oral form, and cost-effectiveness.

The global small molecule drug discovery market is segmented into therapeutic area and process/phase. Based on therapeutic area, the small molecule drug discovery market is further segmented into oncology, central nervous system, cardiovascular, respiratory, orthopedics, immunology, rare diseases, and other therapeutic areas. The oncology segment held a largest share of the market in 2019; however, the rare diseases segment is anticipated to register a higher CAGR in the market during the forecast period. Based on process/phase, the market is subsegmented into target discovery, target validation, lead generation and refinement, and preclinical development. The lead generation and refinement segment held the largest share of the market in 2019; whereas, target discovery is estimated to register the highest CAGR during the forecast period.

The Centre for the Study of Drug Development, Department of Science and Innovation, and Centers for Disease Control and Prevention are some of the essential primary and secondary sources included in the report.

Reasons to Buy:
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the small molecule drug discovery market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global small molecule drug discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan Plc.
  • AstraZeneca
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc.
  • MERCK KGaA
  • Pfizer Inc.
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Small Molecule Drug Discovery Market - By Therapeutic Area
1.3.2 Global Small Molecule Drug Discovery Market - By Process/Phase
1.3.3 Global Small Molecule Drug Discovery Market - By Geography

2. Small Molecule Drug Discovery Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Small Molecule Drug Discovery - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe- PEST Analysis
4.2.2 Asia Pacific- PEST Analysis
4.2.3 Middle East & Africa
4.2.4 South and Central America
4.3 Expert Opinion

5. Global Small Molecule Drug Discovery Market - Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Approval of Small Molecule Drugs
5.1.2 Growing Demand for R&D from Contract Organizations
5.1.3 Rising Adoption of Small Molecules in Chronic Disease Treatments
5.2 Market Restraints
5.2.1 High Drug Development Cost
5.3 Market Opportunities
5.3.1 Increasing Small Molecule-Based Pipeline
5.4 Future Trends
5.4.1 Growing Adoption of Artificial Intelligence in Drug Discovery
5.5 Impact analysis

6. Small Molecule Drug Discovery Market - Global Analysis
6.1 Global Small Molecule Drug Discovery Market Revenue Forecast And Analysis
6.2 Global Small Molecule Drug Discovery Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. Small Molecule Drug Discovery Market - By Therapeutic Area
7.1 Overview
7.2 Small Molecule Drug Discovery Market Share, by Therapeutic Area, 2019 and 2027 (%)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (US$ million)
7.4 Central Nervous System
7.4.1 Overview
7.4.2 Central Nervous System: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (US$ million)
7.5 Cardiovascular
7.5.1 Overview
7.5.2 Cardiovascular: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (US$ million)
7.6 Respiratory
7.6.1 Overview
7.6.2 Respiratory: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (US$ million)
7.7 Orthopedics
7.7.1 Overview
7.7.2 Orthopedics: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (US$ million)
7.8 Immunology
7.8.1 Overview
7.8.2 Immunology: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (US$ million)
7.9 Rare Diseases
7.9.1 Overview
7.9.2 Rare Diseases: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (US$ million)
7.10 Other Therapeutic Areas
7.10.1 Overview
7.10.2 Other Therapeutic Areas: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (US$ million)

8. Small Molecule Drug Discovery Market - By Process/Phase
8.1 Overview
8.2 Small Molecule Drug Discovery Market, by Process/Phase, 2019 and 2027 (%)
8.3 Target Discovery
8.3.1 Overview
8.3.2 Target Discovery: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Target Validation
8.4.1 Overview
8.4.2 Target Validation: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Lead Generation and Refinement
8.5.1 Overview
8.5.2 Lead Generation and Refinement: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Preclinical Development
8.6.1 Overview
8.6.2 Preclinical Development: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (US$ Million)

9. Small Molecule Drug Discovery Market - Geographic Analysis
9.1 North America: Small Molecule Drug Discovery Market
9.1.1 Overview
9.1.2 North America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America Small Molecule Drug Discovery Market, by Therapeutic Area - Revenue and Forecast to 2027 (USD Million)
9.1.4 North America Small Molecule Drug Discovery Market, by Process/ Phase - Revenue and Forecast to 2027 (USD Million)
9.1.5 North America: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
9.1.5.1 US: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.1.1 US: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.1.2 US Small Molecule Drug Discovery Market, by Therapeutic Area - Revenue and Forecast to 2027 (USD Million)
9.1.5.1.3 US Skin aesthetic devices market, by Process/ Phase - Revenue and Forecast to 2027 (USD Million)
9.1.5.2 Canada: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.2.1 Canada: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.2.2 Canada Small Molecule Drug Discovery Market, by Therapeutic Area - Revenue and Forecast to 2027 (USD Million)
9.1.5.2.3 Canada Small Molecule Drug Discovery Market, by Process/ Phase - Revenue and Forecast to 2027 (USD Million)
9.1.5.3 Mexico: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.3.1 Mexico: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.3.2 Mexico Small Molecule Drug Discovery Market, by Therapeutic Area - Revenue and Forecast to 2027 (USD Million)
9.1.5.3.3 Mexico Small Molecule Drug Discovery Market, by Process/ Phase - Revenue and Forecast to 2027 (USD Million)
9.2 Europe: Small Molecule Drug Discovery Market
9.2.1 Overview
9.2.2 Europe: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (USD Millions)
9.2.3 Europe: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.2.4 Europe: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.2.5 Europe: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
9.2.5.1 Germany: Small Molecule Drug Discovery Market
9.2.5.1.1 Germany: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Millions)
9.2.5.1.2 Germany: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.2.5.1.3 Germany: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.2.5.2 United Kingdom: Small Molecule Drug Discovery Market
9.2.5.2.1 United Kingdom: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Millions)
9.2.5.2.2 United Kingdom: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.2.5.2.3 United Kingdom: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.2.5.3 France: Small Molecule Drug Discovery Market
9.2.5.3.1 France: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Millions)
9.2.5.3.2 France: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.2.5.3.3 France: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.2.5.4 Italy: Small Molecule Drug Discovery Market
9.2.5.4.1 Italy: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Millions)
9.2.5.4.2 Italy: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.2.5.4.3 Italy: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.2.5.5 Spain: Small Molecule Drug Discovery Market
9.2.5.5.1 Spain: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Millions)
9.2.5.5.2 Spain: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.2.5.5.3 Spain: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.3 Asia Pacific: Small Molecule Drug Discovery Market
9.3.1 Overview
9.3.2 Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Millions)
9.3.3 Asia Pacific: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.3.4 Asia Pacific: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.3.5 Asia Pacific: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
9.3.5.1 China: Small Molecule Drug Discovery Market
9.3.5.1.1 China: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Millions)
9.3.5.1.2 China: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.3.5.1.3 China: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.3.5.2 Japan: Small Molecule Drug Discovery Market
9.3.5.2.1 Japan: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Millions)
9.3.5.2.2 Japan: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.3.5.2.3 Japan: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.3.5.3 India: Small Molecule Drug Discovery Market
9.3.5.3.1 India: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Millions)
9.3.5.3.2 India: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.3.5.3.3 India: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.3.5.4 South Korea: Small Molecule Drug Discovery Market
9.3.5.4.1 South Korea: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Millions)
9.3.5.4.2 South Korea: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.3.5.4.3 South Korea: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.3.5.5 Australia: Small Molecule Drug Discovery Market
9.3.5.5.1 Australia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Millions)
9.3.5.5.2 Australia: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.3.5.5.3 Australia: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.4 Middle East and Africa: Small Molecule Drug Discovery Market
9.4.1 Overview
9.4.2 Middle East and Africa: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (USD Million)
9.4.3 Middle East and Africa Small Molecule Drug Discovery Market, by Therapeutic Area - Revenue and Forecast to 2027 (USD Million)
9.4.4 Middle East and Africa Immunodiagnostics Market, by Process/Phase - Revenue and Forecast to 2027 (USD Million)
9.4.5 Middle East and Africa: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
9.4.5.1 Saudi Arabia: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (USD Million)
9.4.5.1.1 Saudi Arabia: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (USD Million)
9.4.5.1.2 Saudi Arabia Small Molecule Drug Discovery Market, by Therapeutic Area - Revenue and Forecast to 2027 (USD Million)
9.4.5.1.3 Saudi Arabia Immunodiagnostics, by Process/Phase - Revenue and Forecast to 2027 (USD Million)
9.4.5.2 UAE: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (USD Million)
9.4.5.2.1 UAE: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (USD Million)
9.4.5.2.2 UAE Small Molecule Drug Discovery Market, by Therapeutic Area - Revenue and Forecast to 2027 (USD Million)
9.4.5.2.3 UAE Immunodiagnostics Market, by Process/Phase - Revenue and Forecast to 2027 (USD Million)
9.4.5.3 South Africa: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (USD Million)
9.4.5.3.1 South Africa: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (USD Million)
9.4.5.3.2 South Africa Small Molecule Drug Discovery Market, by Therapeutic Area - Revenue and Forecast to 2027 (USD Million)
9.4.5.3.3 South Africa Immunodiagnostics Market, by Process/Phase - Revenue and Forecast to 2027 (USD Million)
9.5 South and Central America: Small Molecule Drug Discovery Market
9.5.1 Overview
9.5.2 South and Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Million)
9.5.3 South and Central America Small Molecule Drug Discovery Market, by Therapeutic Area - Revenue and Forecast to 2027 (USD Million)
9.5.4 South and Central America Small Molecule Drug Discovery Market, by Process/Phase - Revenue and Forecast to 2027 (USD Million)
9.5.5 South and Central America: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
9.5.5.1 Brazil: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Million)
9.5.5.1.1 Brazil: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Million)
9.5.5.1.2 Brazil Small Molecule Drug Discovery Market, by Therapeutic Area - Revenue and Forecast to 2027 (USD Million)
9.5.5.1.3 Brazil Small Molecule Drug Discovery Market, by Process/Phase - Revenue and Forecast to 2027 (USD Million)
9.5.5.2 Argentina: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Million)
9.5.5.2.1 Argentina: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Million)
9.5.5.2.2 Argentina Small Molecule Drug Discovery Market, by Therapeutic Area - Revenue and Forecast to 2027 (USD Million)
9.5.5.2.3 Argentina Small Molecule Drug Discovery Market, by Process/Phase - Revenue and Forecast to 2027 (USD Million)

10. Impact of COVID-19 Pandemic on Global Small Molecule Drug Discovery Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

11. Small Molecule Drug Discovery Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview

12. Small Molecule Drug Discovery Market -Company Profiles
12.1 Pfizer Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Bristol-Myers Squibb Company
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck KGaA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 GlaxoSmithKline plc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 AstraZeneca
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Johnson & Johnson Services, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Gilead Sciences, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Teva Pharmaceutical Industries Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Boehringer Ingelheim International GmbH
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Allergan Plc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
Note: Product cover images may vary from those shown
3 of 3
  • Johnson and Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd
  • Boehringer Ingelheim International GmbH
  • Allergan Plc.
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • MERCK KGaA
  • GlaxoSmithKline plc.
  • AstraZeneca
  • Gilead Sciences, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll